GENE ONLINE|News &
Opinion
Blog

Lifebit Provides BioMedical ICT Solution for Hong Kong’s Large-Scale Genome Sequencing Project

by Tyler Chen
Share To

As announced last year, Hong Kong will initiate the pilot phase of a large-scale genome sequencing project in mid-2021. On May 25th, a biomedical big data firm, Lifebit, successfully scored a four year contract with the Hong Kong Genome Institute (HKGI) to support the plan.

 

PICT Infrastructure and Cloud Technology

Lifebit will provide a highly scalable cloud and HPC infrastructure to transform raw sequencing data into clinical diagnosis and research insights in as little as three hours. Also, biomedical researchers worldwide can gain secure access to the data, facilitating the understanding of undiagnosed and hereditary diseases.

“Precision medicine requires vast amounts of data to be analyzed, and we believe federated analysis will play a key role in powering the Project for HKGI.” Thorben Seeger, Lifebit VP Commercial, said.

 

$154 Million Funding

The goal of the Hong Kong Genome Project is to sequence 50,000 whole genomes with 20,000 cases in six years to understand the mechanism of serious diseases and the genetic composition of Hong Kong citizens, which could potentially lead to more personalized, precise, and innovative therapeutics development.

With objectives and strategy revealed in 2020, the Hong Kong Genome Project has obtained fundings of $154 million (1.2 billion Hong Kong Dollars) from the government. It will enter three stages in the following years. First, a pilot phase that sequenced 2,000 cases with undiagnosed diseases or hereditary cancer will be conducted. This phase will gain a total of 5,000 whole genomes.

Then, 18,000 cases that included diseases in the pilot phase and those that can benefit from the whole genome sequencing will be processed in two phases. Overall, the plan will gain insights into 40,000 to 50,000 whole genomes.

Other than the project, Hong Kong will also work on other seven aspects:

  1. Provide more genome and hereditary clinical services
  2. Foster local talents
  3. Educate the public on the idea of genetic testing
  4. Increase genetic-testing focused laboratories and improve the transferal system
  5. Build biobanks
  6. Implement policies and restrictions to avoid genetic discrimination at work or insurance
  7. Promote consultation with doctors before genetic testing

Currently, China, Singapore, Iceland, Israel, Finland, and Irland have implemented their genome sequencing project as well.

Related Article: Singapore Targets Widespread Implementation of Precision Medicine, Launches Phase II of its 10-Year Plan

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Researchers Have Now Identified the Complete Human Genome without Any Gaps
2022-04-06
UMP Healthcare Expands Free Telemedicine and Drug Delivery to COVID-19 Patients
2022-03-31
Bavarian Nordic Establishes Asia Link for Its RSV Vaccines
2022-03-24
LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!